Ayyadevara VSSA, Wertheim G, Gaur S, Chukinas JA, et al. DYRK1A inhibition results in MYC and ERK activation rendering KMT2A-R acute lymphoblastic leukemia cells sensitive to BCL2 inhibition. Leukemia 2025 Mar 27. doi: 10.1038/s41375-025-02575.
PMID: 40148558